WESTFORD, Mass., Dec. 29, 2014 /PRNewswire/ -- Cynosure, Inc.
(NASDAQ: CYNO), which designs, manufactures and markets medical
devices for aesthetic procedures and precision surgical
applications worldwide, today announced that its senior
management will present at the 17th Annual Needham
Growth Conference at 8:00 a.m. (ET)
on Tuesday, January 13, 2015 in
New York City.
The presentation by Cynosure Chairman and Chief Executive
Officer Michael Davin and President
and Chief Financial Officer Timothy
Baker will be available via live and archived audio webcast
accessible through a link on the Investor Relations section of the
Company's website, www.cynosure.com.
About Cynosure, Inc.
Cynosure develops and markets
aesthetic treatment systems that enable plastic surgeons,
dermatologists and other medical practitioners to perform
non-invasive and minimally invasive procedures to remove hair,
treat vascular and benign pigmented lesions, remove multi-colored
tattoos, revitalize the skin, liquefy and remove unwanted fat
through laser lipolysis, reduce cellulite, clear nails infected by
toe fungus and ablate sweat glands. Cynosure's product
portfolio is composed of a broad range of energy sources including
Alexandrite, diode, Nd: YAG, picosecond, pulse dye, Q-switched
lasers, intense pulsed light and radiofrequency technology.
Cynosure sells its products globally under the Cynosure, Palomar,
ConBio and Ellman brand names through a direct sales force in
the United States, Canada, Mexico, France, Germany, Spain, the United
Kingdom, Australia,
China, Japan and Korea, and through international
distributors in approximately 120 other countries. For
corporate or product information, visit Cynosure's website at
www.cynosure.com.
Contact:
Scott
Solomon
Vice President
Sharon Merrill Associates, Inc.
617.542.5300
cyno@investorrelations.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/cynosure-to-present-at-17th-annual-needham-growth-conference-300014157.html
SOURCE Cynosure, Inc.